Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lantheus (LNTH)
NASDAQ:LNTH
Lantheus (LNTH) Stock Price & Analysis
1,032 Followers
LNTH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$50.20 - $100.85
Previous Close$76.01
Volume1.07M
Average Volume (3M)942.17K
Market Cap
$5.27B
Enterprise Value$5.22B
Total Cash (Recent Filing)$614.13M
Total Debt (Recent Filing)$561.28M
Price to Earnings (P/E)11.6
Beta0.86
Next Earnings
Aug 01, 2024EPS Estimate
$1.8Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.55
Shares Outstanding69,312,588
10 Day Avg. Volume1,335,651
30 Day Avg. Volume942,168
Standard Deviation0.17
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)8.68
Price to Sales (P/S)5.63
Price to Cash Flow (P/CF)11.70
P/FCF Ratio11.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.33
Enterprise Value/Gross Profit8.97
Enterprise Value/Ebitda40.44
Forecast
1Y Price Target
$101.71Price Target Upside36.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Lantheus News
PremiumCompany Announcements
Lantheus Stockholders Approve Key Governance and Compensation Plans
Bulls Say, Bears Say
Bulls Say
Financial Outlook And GuidanceThe company's strategic position is expected to support longer-term growth, with multiple assets in radiopharma indicating a strong future pipeline.
Financial Position And StabilityImpressive cash position with access to additional credit underlines financial stability, suggesting a robust platform for future investments and growth.
Product Acceptance And Market GrowthPylarify revenue growth outpaces expectations, signaling increased market acceptance and potential for significant sales in the coming year.
Bears Say
Product CompetitivenessConcern over the potential commercial competitiveness of PNT2002 could lead to a decline in investor confidence in Lantheus stock.
Regulatory And Payment IssuesThe pass-through status expiration may alter the payment scheme for a portion of patients, potentially impacting Lantheus's revenue.
Stock VolatilityRecent volatility in Lantheus stock suggests that while some downside may already be reflected in the price, further drops cannot be ruled out.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LNTH FAQ
What was Lantheus’s price range in the past 12 months?
Lantheus lowest stock price was $50.20 and its highest was $100.85 in the past 12 months.
What is Lantheus’s market cap?
Currently, no data Available
When is Lantheus’s upcoming earnings report date?
Lantheus’s upcoming earnings report date is Aug 01, 2024 which is in 84 days.
How were Lantheus’s earnings last quarter?
Lantheus released its earnings results on May 02, 2024. The company reported $1.69 earnings per share for the quarter, beating the consensus estimate of $1.544 by $0.146.
Is Lantheus overvalued?
According to Wall Street analysts Lantheus’s price is currently Undervalued.
Does Lantheus pay dividends?
Lantheus does not currently pay dividends.
What is Lantheus’s EPS estimate?
Lantheus’s EPS estimate is $1.8.
How many shares outstanding does Lantheus have?
Lantheus has 69,312,590 shares outstanding.
What happened to Lantheus’s price movement after its last earnings report?
Lantheus reported an EPS of $1.69 in its last earnings report, beating expectations of $1.544. Following the earnings report the stock price went up 16.011%.
Which hedge fund is a major shareholder of Lantheus?
Among the largest hedge funds holding Lantheus’s share is Private Capital Management, LLC. It holds Lantheus’s shares valued at 35M.
---
Lantheus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$101.71 (36.51% Upside)
$101.71 (36.51% Upside)
Blogger Sentiment
Bullish
LNTH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-19.18%
12-Months-Change
Fundamentals
Return on Equity
66.21%
Trailing 12-Months
Asset Growth
35.73%
Trailing 12-Months
Company Description
Lantheus
Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.
---
LNTH Company Deck
---
LNTH Earnings Call
Q1 2024
0:00 / 0:00
---
LNTH Revenue Breakdown
65.67% PYLARIFY
21.58% DEFINITY
6.74% TechneLite
4.00% Strategic Partnerships and other revenue
2.01% Other
---
LNTH Stock 12 Month Forecast
Average Price Target
$101.71
▲(36.51% Upside)
Technical Analysis
Best Analysts Covering LNTH
1 Year
1 Year Success Rate
15/22 ratings generated profit
1 Year Average Return
+55.15%
reiterated a buy rating 7 days ago
Copying Richard Newitter's trades and holding each position for 1 Year would result in 68.18% of your transactions generating a profit, with an average return of +55.15% per trade.
---